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Abstract
The M3 subtype of muscarinic acetylcholine receptors (M3-mAChR) plays a protective role in myocardial ischemia and
microRNAs (miRNAs) participate in many cardiac pathophysiological processes, including ischemia-induced cardiac injury.
However, the role of miRNAs in M3-mAChR mediated cardioprotection remains unexplored. The present study was designed
to identify miRNAs that are involved in cardioprotective effects of M3-mAChR against myocardial ischemia and elucidate the
underlying mechanisms. We established rat model of myocardial ischemia and performed miRNA microarray analysis to
identify miRNAs involved in the cardioprotection of M3-mAChR. In H9c2 cells, the viability, intracellular free Ca
2+
concentration ([Ca
2+]i), intracellular reactive oxygen species (ROS), miR-376b-5p expression level, brain derived neurophic
factor (BDNF) and nuclear factor kappa-B (NF-kB) levels were measured. Our results demonstrated that M3-mAChR
protected myocardial ischemia injury. Microarray analysis and qRT-PCR revealed that miR-376b-5p was significantly up-
regulated in ischemic heart tissue and the M3-mAChRs agonist choline reversed its up-regulation. In vitro, miR-376b-5p
promoted H2O2-induced H9c2 cell injuries measured by cells viability, [Ca
2+]i and ROS. Western blot and luciferase assay
identified BDNF as a direct target of miR-376b-5p. M3-mAChR activated NF-kB and thereby inhibited miR-376b-5p
expression. Our data show that a novel M3-mAChR/NF-kB/miR-376b-5p/BDNF axis plays an important role in modulating
cardioprotection. MiR-376b-5p promotes myocardial ischemia injury possibly by inhibiting BDNF expression and M3-mAChR
provides cardioprotection at least partially mediated by the downregulation of miR-376b-5p through NF-kB. These findings
provide new insight into the potential mechanism by which M3-mAChR provides cardioprotection against myocardial
ischemia injury.
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Introduction
Ischemic heart disease is the leading cause of death in the
industrialized world [1]. Myocardial ischemia could induce unstable
angina,arrhythmia,myocardial infarction or itsneopathy,leading to
sudden cardiac death [2–4]. While many drugs failed to efficaciously
treat cardiac death with myocardial ischemia and myocardial
infarction [5], recent studies have shown that M3 subtype of
muscarinic acetylcholine receptors (M3-mAChR) in the heart have
cardioprotective effect against myocardial ischemia [6–10].
MicroRNAs (miRNAs) emerge as important regulator of gene
expression and have been implicated in numerous cardiovascular
pathological processes, including cardiac fibrosis, cardiac hypertro-
phy,heartfailureand cardiacarrhythmia[11–14].Specially,several
miRNAsincludingmiRNA-320 [15],miRNA-21[16] and miRNA-
494 [17] are involved in myocardial ischemia. However, the
potential role of miRNAs in cardioprotection of M3-mAChR
remains to be elucidated. Therefore, the present study aimed to
explore the contribution of miRNAs to cardioprotective effects
mediated by M3-mAChR against myocardial ischemia. Our results
revealed for the first time that miR-376b-5p increased myocardial
ischemiainjuryand wasinvolvedinM3-mAChR’scardioprotection.
Materials and Methods
Ethics Statement
All experimental protocols were pre-approved by the Experimen-
tal Animal Ethic Committee of Harbin Medical University, China
(Animal Experimental Ethical Inspection Protocol No. 2009104).
Use of animals was confirmed with the Guide for the Care and Use
of Laboratory Animals published by the US National Institutes of
Health (NIH Publication No. 85–23, revised 1996).
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Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine
serum (FBS), trypsin and other tissue culture reagents were
obtained from Life Technologies, Inc (Carlsbad, CA, USA). The
bicinchoninic acid (BCA) protein assay reagents were obtained
from Pierce (Rockford, IL, USA). Sodium pentobarbital was
obtained from Shanghai Chemicals (Shanghai, China). Choline
chloride (choline, agonist of M3-mAChR), 4-diphenylacetoxy-N-
methylpiperidine methiodide (4DAMP, antagonist of M3-
mAChR) and lipopolysaccharide (LPS, an agonist of NF-kB) were
obtained from Sigma (St. Louis, MO, USA). MiRNAs were from
Shanghai GenePharma Co.,Ltd.(Shanghai, China). Lipofectamine
2000 and Alexa FluorH 800 goat anti-mouse IgG or anti-rabbit
IgG were purchased from Invitrogen (Carlsbad, CA,USA). Total
RNA Purification Kit was from Norgen Biotek (Thorold, ON,
Canada). The mirVanaTM qRT-PCR miRNA Detection Kit was
from Ambion (Austin, TX, USA). Bio-Rad Protein Assay Kit was
obtained from Bio-Rad, (Mississauga, ON, Canada). 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
was from Roche Diagnostics GmBH (Mannhein, Germany).
29,79- dichlorodihydrofluorescein diacetate (DCFH-DA) was from
Molecular Probes (Eugene, USA). Anti-nuclear factor kappa-B
(NF-kB) antibody and anti-GAPDH were purchased from Santa
Cruz Biotechnology (Santa Cruz, CA, USA). Anti-brain derived
neurophic factor (BDNF) antibody was obtained from abcam
(Lake Placid, NY, USA). Luciferase reporter assay kit was from
Promega (Madison, WI, USA). All other chemicals were
purchased from either Sigma. The purity of all reagents was at
least analytical grade.
Establishment of rat myocardial ischemia model
Male Wistar rats (weight 280–300 g) were randomly divided
into four groups: control, ischemia, choline (agonist of M3-
mAChR), and choline+4DAMP (antagonist of M3-mAChR)
groups. All treatments were administered via the lingual vein with
doses of choline and 4DAMP as described previously [7]. Choline
(10 mg/kg, i.v.) was administered 10 min before the occlusion. For
choline+4DAMP group, 4DAMP (0.12 mg/kg) was administered
5 min before choline. Rat model of myocardial ischemia was
established as previously described [8]. Briefly, the rats were
anesthetized intraperitoneal injection with sodium pentobarbital
(40 mg/kg) and the respiration of rats was controlled by the
volume-controlled rodent ventilator. The ventilator setting and the
level of anesthesia were adjusted to maintain the animal in an
anaesthetize status without spontaneous breathing efforts. A left
thoracotomy was performed at the 3rd–4th rib and a segment of
saline-soaked 5-0 sutures was looped around the left anterior
descending (LAD) coronary artery, near its origin from the left
coronary artery. Successful occlusion was observed by electrocar-
diographic ST-segment elevation. The chest was closed before the
rats were weaned from the ventilator and extubated. Rats were put
into cage to breed with normal water and feeds after waking up.
Mortality rate of the rats were calculated and compared after 24 h
myocardial infarction. After 24 h ischemia, rats were reanesthe-
tized and the hearts were removed for the measurement of
myocardial infarct size and microRNA microarray analysis.
Control group without drugs was handled in the same manner
except that the coronary artery was not ligated.
Measurement of myocardial infarct size
Ventricular tissues were dissected from the animals after 24 h
ischemia and kept overnight at 24u. Frozen ventricles were sliced
into 2 mm thick sections, and then incubated in 1% triphenylte-
trazolium chloride (TTC) at 37uC in 0.2 M Tris buffer (pH 7.4)
for 30 min. The non-ischemia area was stained as red and infarct
area grey white. Size of the infarcted area was estimated by weight
as a percentage of the left ventricle [7].
MicroRNA microarray analysis
After 24 h ischemia, surrounding tissues of infarcted area from
ventricular were departed for microRNA microarray analysis by
using hybridization to mParafloHmicrofluidics microarrays (LC
Sciences) in the version of the Sanger miRBase database Release
10.1 (Release 12, http://microrna.sanger.ac.uk/). Each detection
probe consisted of a chemically modified nucleotide-coding
segment complementary to the target miRNA or other target
and a spacer segment of polyethylene glycol to extend the coding
segment away from the substrate. Each miRNA probe was
represented 5 times on a single microarray, and the control probes
were spiked into the RNA samples before the labeling. The
detection probes were prepared by in situ synthesis using PGR
(photogenerated) chemistry to allow highly sensitive and specific
detection of miRNAs. The mParafloH technology enabled on-chip
synthesis, ensuring high probe quality and tight process control.
Cell culture
H9c2 myoblast cell line (the rat embryonic ventricular
myocardial cell line) were cultured and maintained as monolayer
in high glucose DMEM, supplemented with 10% heat inactivated
FBS, 100 U/ml penicillin and 100 mg/ml streptomycin, at 37uC
in a humidified incubator with 5% CO2. H9c2 cells were plated at
a density of 5000 cells/cm
2 and allowed to proliferate in growth
medium. Medium was changed every 3 days.
Transfection of miRNAs and miRNA inhibitor
Rat miR-376b-5p, miR-539, 29-O-methyl-modified antisense
oligoribonucleotides of miR-376b-5p (AMO-376b-5p, miR-376b-
5p inhibitor) and miR-376b-5p negative control (miR-NC) were
synthesized by Shanghai GenePharma. The sequence of AMO-
376b-5p was antisense of the mature miRNA sequence (for rat: 59-
GUGGAUAUUCCUUCUAUGGUUA-39) and miR-NC was a
random sequence. AMO-376b-5p contained 29-O-methyl modi-
fication at every base and a 39C3-containing amino linker.
H9c2 cells were transfected with miR-NC (100 nM), miR-376b-
5p (100 nM), miR-539 (100 nM), miR-376b-5p (100 nM) and
AMO-376b-5p (100 nM) using lipofectamine 2000 according to
the manufacturer’s instruction and incubated at 37uC for 24 h.
Subsequently, cells were maintained in the culture until analysis
[11].
MTT assay
H9c2 cells were seeded into 96-well plates at the density of 2610
4/
well. After 24 h, MiR-539, miR-NC, miR-376b-5p and AMO-376b-
5p were transfected and incubated for 24 h, followed by treatment
with H2O2(50 mM)for12 h.Then10 ml MTT reagents (0.5 mg/ml)
was added and incubated for 4 h. After dissolving the formazine
granulars with 150 ml dimethyl sulphoxide (DMSO), the absorbance
at 570 nm was measured by using a microplate reader. The cell
viability=(Acontrol group2Aexperimental group)/Acontrol group6100%.
Measurement of intracellular free Ca
2+
H9c2 cells were seeded into 6-well plates. The cells were treated
with H2O2 (50 mM) for 12 h before transfection with miRNAs.
The [Ca
2+]i levels were measured 24 h after transfection. Pluronic
F-127 was used as a dispersing agent to facilitate the loading of
cells with a final concentration of 0.012% Fluo-3/AM in the
loading medium. Changes in the fluorescence intensity of Fluo-3/
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microscopy (FV-300; Olympus, Tokyo, Japan) at 488 nm
excitation and 530 nm emission wavelengths. The acquisition
rate was one frame at 10 s intervals and [Ca
2+]i was monitored for
300 s.
Measurement of intracellular ROS
Intracellular reactive oxygen species (ROS) were stained using
DCFH-DA. H9c2 cells were seeded into 6-well plates. The cells
were treated with H2O2 (50 mM) for 12 h before transfection with
miRNAs. The intracellular ROS levels were measured 24 h after
transfection. The cells were washed with serum-free DMEM and
incubated with 10 mmol/L DCFH-DA in the loading medium in
5% CO2/95% air at 37uC for 20 min. After DCFH-DA was
removed, the cells were washed twice and the DCF fluorescence
intensity was observed and photographed by laser scanning
confocal microscopy (FV-300; Olympus, Tokyo, Japan) at
488 nm excitation and 525 nm emission wavelengths. The
acquisition rate was one frame at 10 s intervals and ROS was
monitored for 300 s.
RT-PCR
Total RNA was isolated from H9c2 cells or rat myocardium
with Total RNA Purification Kit. qRT-PCR for miR-376b-5p,
miR-539 was performed on a GeneAmp 5700 thermocycler using
mirVanaTM miRNA Detection Kit following the manufacturer’s
instructions. U6 was used as an internal control. The primers were
as follows: U6 primers q59-CTCCGATAGATCTGCCCTCTT-
GAA-39 (forward), 59-CGCTTCACGAATTTGCGTGTCAT-39
(reverse). miR-376b-5p primers 59-GGGGGTGGATATTCC-
TTCT-39 (forward), 59-CAGTGCGTGTCGTGGAGT-39 (re-
verse). miR-539 primers 59-GGGGGAGAAATTATCCTT-39
(forward), 59-TGCGTGTCGTGGAGTC-39 (reverse).
Western blot analysis
Whole cell extract and nuclear extract were extracted from
H9c2 cells. The protein content was determined with Bio-Rad
Protein Assay Kit using bovine serum albumin as the standard.
Protein sample (50 mg) was fractionated by 7.5–10% SDS-PAGE
and transferred to nitrocellulose membranes. The membranes
were blocked in 5% milk PBS-Tween20 (PBST) for 3 h and
incubated overnight at 4uC with the following primary antibodies:
BDNF, NF-kB or GAPDH as internal controls, followed by
incubation with Alexa FluorH 800 goat anti-mouse IgG or anti-
rabbit IgG (1:10000) for 1 h. The images were captured on the
Odyssey Infrared Imaging System (LI-COR Bioscience, Lincoln,
NE, USA) and band intensity was quantified using Odyssey v1.2
software.
Luciferase activity assay
A fragment of the 39-untranslated region (39-UTR) of BDNF
containing the putative miR-376b-5p binding sequence was
cloned into psiCHECK-2 (Renilla luciferase vector) and the
construct (0.5 mg) was transfected into HEK 293T cells with miR-
NC, miR-376b-5p, AMO-376b-5p or AMO-376b-5p negative
control (AMO-NC). After 24 h, luciferase activities were measured
with a dual luciferase reporter assay kit on a luminometer (Lumat
LB9507) (EG&G Berthold, Bad Wildbad, Germany).
Statistical analysis
Average data were presented as mean 6 standard error and
were analyzed by analysis of variance (ANOVA) followed by
Bonferroni’s post-hoc test. P,0.05 was considered statistically
significant.
Results
MicroRNAs are involved in M3-mAChR mediated
cardioprotection against myocardial ischemia in rat
We established rat model of myocardial ischemia and examined
mortality rate and myocardial infarct size. Choline significantly
reduced the infarct size, which was reversed by 4DAMP (Figure 1A
and B). As expected, choline group showed an obvious decrease in
mortality rate (8.33%, n=12, 1 died) compared to control group
subjected to the same procedure (28.6%, n=14, 4 died), and
4DAMP increased mortality rate (14.3%, n=14, 2 died) compared
to choline group. Taken together, these results confirmed that M3-
mAChR provides cardioprotection against myocardial ischemia.
To determine whether miRNAs are involved in M3-mAChR
mediated cardioprotection, we performed miRNA microarray
analysis and identified 12 differentially upregulated miRNAs upon
myocardial ischemia, among which 10 miRNAs were differentially
downregulated by M3-mAChR agonist choline (Table 1). While
miR-199a, miR-376b-5p, miR-539 and miR-106 were all
significantly upregulated (more than 3 times compared to the
control), only miR-376b-5p and miR-539 were downregulated to
the level similar to the control group after treatment with choline.
To confirm the expression changes of miR-376b-5p and miR-
539 in myocardial ischemia, next we performed qRT-PCR
analysis and found that miR-376b-5p and miR-539 were
significantly upregulated upon myocardial ischemia and down-
regulated by choline (P,0.05, Figure 1C and D). These data
demonstrate that miR-376b-5p and miR-539 are significantly
upregulated in ischemic heart of the rats and M3-mAChR agonist
choline could reverse their upregulation. Therefore, miR-376b-5p
and miR-539 appear to be involved in M3-mAChR mediated
cardioprotection against myocardial ischemia.
MiR-376b-5p promotes H2O2 induced H9c2 cells injury
To determine the involvement of miR-376b-5p and miR-539 in
myocardial ischemia, we used H9c2 cells as an in vitro model.
MTT assay showed that miR-376b-5p significantly enhanced
H2O2-induced inhibition of H9c2 cells viability (P,0.05), which
was reversed by AMO-376b-5p. However, miR-539 had no
significant effect on H2O2-induced inhibition of H9c2 cells
viability (Figure 2A). These results suggest that miR-539 is unlikely
involved in myocardial ischemia and we focused on miR-376b-5p
in the following experiments.
The overload of intracellular free Ca
2+ concentration ([Ca
2+]i) is
an important cause of cell injury [7,9]. Therefore, we examined
[Ca
2+]i in H2O2-treated H9c2 cells and found that miR-376b-5p
significantly increased the overload of [Ca
2+]i (P,0.05) while
AMO-376b-5p reversed this increase (Figure 2B).
Moreover, miR-376b-5p significantly increased the intracellular
ROS in H2O2-treated H9c2 cells (P,0.05) and this effect was
reversed by AMO-376b-5p (Figure 2C). Taken together, these
results suggest that miR-376b-5p promotes H2O2-induced H9c2
cells injury.
M3-mAChR inhibits H2O2 induced upregulation of miR-
376b-5p in H9c2 cells
To examine further miR-376b-5p expression in ischemic
myocardial cells and the effects of M3-mAChR on miR-376b-5p
expression in vitro, H9c2 cells were co-incubated with H2O2
(50 mM), choline (1 mM) or 4DAMP (5 nM) for 12 h. The results
showed that H2O2 significantly upregulated the miR-376b-5p
MiR-376b is Involved in M3-R’s Cardioprotection
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mAChR agonist choline (Figure 3). Furthermore, M3-mAChR
antagonist 4DAMP reversed the effect of choline on miR-376b-5p.
These results are consistent with the results of gene array analysis
verified by qRT-PCR (Figure 1C) and suggest that M3-mAChR
inhibits the up-regulation of miR-376b-5p stimulated by H2O2 in
H9c2 cells.
BDNF is a target gene of miR-376b-5p in cardiac
myocytes
To further explore the role of miR-376b-5p in myocardial
ischemia, we predicted the targets of miR-376b-5p by targetScan
Release 5.1 online (www.targetscan.org) and focused on BDNF
(Figure 4A). Next we determined the expression of BDNF at the
protein level in H9c2 cells and found that miR-376b-5p
significantly reduced the expression of BDNF (P,0.05), and this
reduction was reversed by AMO-376b-5p (Figure 4B). These
results suggest that BDNF is a target gene of miR-376b-5p.
To confirm that miR-376b-5p could directly bind to BDNF gene
and inhibit its expression, a reporter construct with the insertion of a
fragment of the 39-UTR of BDNF mRNA containing the predicted
miR-376b-5p binding site was transfected into HEK 293T cells.
Luciferase assay showed that miR-376b-5p significantly reduced the
luciferase activity(P,0.05) while AMO-376b-5p significantly increased
the luciferase activity (P,0.05) (Figure 4C). Taken together, these data
prove that miR-376b-5p directly inhibits BDNF expression.
Figure 1. MiRNA is involved in M3-mAChR mediated cardioprotection against myocardial ischemia in rat. Choline (10 mg/kg, i.v.) was
administrated 10 min before occlusion. 4DAMP (0.12 mg/kg) was administered 5 min before choline. (A) Representative infarct photographs. (B)
Infarct size. Values were expressed as mean 6 SEM; n=8; *P,0.05 vs. Control;
#P,0.05 vs. Choline. (C) Choline reversed ischemia-induced miR-376b-
5p up-regulation. (D) Choline reversed ischemia-induced miR-539 up-regulation. Values were expressed as mean 6 SEM; n=3; *P,0.05 vs. Control,
#P,0.05 vs. Ischemia.
doi:10.1371/journal.pone.0032571.g001
Table 1. The levels of differentially expressed miRNAs in the
rat sufferred from myocardial ischemia or administrated with
choline after ischemia.
Probe_ID Control Ischemia Ischemia-choline
rno-miR-199a 1 12.7 2.30
rno-miR-449 1 1.80 1.20
rno-miR-376b-5p 1 9.70 1.87
rno-miR-539 1 4.00 0.81
rno-miR-106 1 3.15 0.15
rno-miR-92 1 2.52 1.11
rno-miR-135b 1 1.80 1.16
rno-miR-349 1 1.58 0.41
rno-miR-122a 1 1.65 1.10
rno-miR-18 1 2.00 1.03
Male Wistar rats were divided into control, ischemia and choline chloride
(choline, agonist of M3-mAChR) groups. Myocardial ischemia model was
induced for 24 h. Choline (10 mg/kg, i.v.) was administrated 10 min before
occlusion. After 24 h ischemia, ventricular tissues were dissected for miRNA
microarray analysis. MiRNAs levels were calculated based on the normalization
to control group (set as 1).
doi:10.1371/journal.pone.0032571.t001
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miR-376b-5p expression in H9c2 cells
Previous studies demonstrated that M3-mAChR could activate
NF-kB [18–20]. Moreover, 3 binding sites of NF-kB were
predicted on the promoter of miR-376b-5p gene by TFSEARCH
(Figure 5A). Therefore, we postulated that NF-kB possibly
mediates the inhibitory effects of M3-mAChR on miR-376b-5p
expression.
To verify that M3-mAChR could activate NF-kB, we
determined nuclear NF-kB protein level in H9c2 cells. Western
blot analysis showed that nuclear NF-kB level was significantly
increased (P,0.05, Figure 5B) after treatment with choline with no
significant variance of total NF-kB level, suggesting that M3-
mAChR could activate NF-kB.
Next we measured miR-376b-5p expression by qRT-PCR in
H9c2 cells treated with LPS (100 ng/ml), which is known to
activate NF-kB in many previous studies [21–23]. As expected,
LPS significantly activated NF-kB( P,0.05, Figure 5C) with no
significant variance of total NF-kB level. Furthermore, LPS
significantly reduced miR-376b-5p expression (P,0.05,
Figure 5D). Collectively, these data indicate that NF-kB mediates
the inhibitory effect of M3-mAChR on miR-376b-5p expression.
Discussion
In the present study, for the first time, we found that miR-376b-
5p inhibited the expression of BDNF and miR-376b-5p promoted
H2O2-induced H9c2 cells injury, indicating that miR-376b-5p
promoted myocardial ischemia injury possibly by inhibiting the
expression of BDNF. Moreover, we found that M3-mAChR
inhibited miR-376b-5p expression by activating NF-kB. These
findings provide new insight into the potential mechanism of
cardioprotection of M3-mAChR against myocardial ischemia.
First, we observed that M3-mAChR decreased infarct size and
mortality rate in rat models, consistent with previous studies
showing that M3-mAChR has the protective effect against
myocardial ischemia [6–10]. Next, to explore the underlying
mechanisms responsible for our observation, we focused on
miRNAs, given their emerging role in the pathogenesis of the
cardiovascular system including myocardial ischemia [11–17].
Based on microarray analysis and further validation by qRT-PCR,
we postulated that the upregulation of miR-376b-5p and miR-539
is involved in myocardial ischemia and M3-mAChR may protect
against myocardial ischemia via the downregulation of miR-376b-
5p and miR-539 expression.
H9c2 cells were treated with H2O2 for 12 h to simulate
myocardial ischemia injury, which was employed as in vitro model
Figure 2. MiR-376b-5p promotes H2O2-induced H9c2 cells injury. H9c2 cells were pre-treated with H2O2 (50 mM) for 12 h and then
transfected with miR-376b-5p negative control (miR-NC), miR-376b-5p, miR-539, and 29-O-methyl-modified antisense oligoribonucleotides of miR-
376b-5p (AMO-376b-5p, miR-376b-5p inhibitor) for 24 h. (A) MTT assay. MiR-376b-5p, not miR-539, reduced cell viability in H2O2-treated H9c2 cells.
n=19 values from 5 independent experiments. (B) Intracellular Ca
2+ concentration ([Ca
2+]i) fluorescence intensity. MiR-376b-5p significantly increased
[Ca
2+]i and this effect was reversed by AMO-376b-5p (AMO). n=29 cells from 5 independent experiments. (C) Reactive oxygen species (ROS)
fluorescence intensity. MiR-376b-5p significantly increased relative fluoresence intensity of ROS. n=12 cells from 3 independent experiments. Values
were expressed as mean 6 SEM; *P,0.05 vs. Control,
#P,0.05 vs. H2O2+miR-NC,
@P,0.05 vs. H2O2+miR-376b-5p. FI: fluorescence intensity.
doi:10.1371/journal.pone.0032571.g002
Figure 3. M3-mAChR inhibits the up-regulation of miR-376b-5p
stimulated by H2O2 in H9c2 cells. H9c2 cells were co-incubated
with H2O2 (50 mM), choline (1 mM) and 4DAMP (5 nM) for 12 h. MiR-
376b-5p expression was determined by qRT-PCR. U6 served as an
internal control for the normalization. Values were expressed as mean
6 SEM; n=4; **P,0.01 vs. Control,
##P,0.01 vs. H2O2+choline,
@P,0.05 vs. H2O2+choline+4DAMP.
doi:10.1371/journal.pone.0032571.g003
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efficiency was measured by real-time PCR. MiR-376b-5p level
was upregulated more than 3 times after transfection (Figure S1),
demonstrating the efficient transfection. Notably, miR-376b-5p
but not miR-539 was implicated in reduced H9c2 cells viability
induced by H2O2. Therefore, miR-376b-5p was chosen for further
characterization.
TargetScan Release 5.1 was used to predict the target genes of
miR-376b-5p. Although 1134 potential targets of miR-376b-5p
were predicted, only a few of them have been reported to be
involved in myocardial ischemia, including insulin-like growth
factor 2 mRNA binding protein 2 [24,25], ryanodine receptor 2
[26–28] and BDNF [29–35]. Given recent studies demonstrating
that BDNF was also expressed in the heart where it protected
against myocardial ischemia injury [29–35], we proposed that
BDNF is one potential target of miR-376b-5p in the heart. Our
Western blot analysis and luciferase assay experiments demon-
strated that miR-376b-5p could directly bind to BDNF gene and
inhibit its expression, providing support for our hypothesis that
miR-376b-5p promotes myocardial ischemia injury possibly via
the downregulation of BDNF.
To determine the potential mechanism by which M3-mAChR
inhibited miR-376b-5p expression, TFSEARCH was used to
identify transcription factors that bind to the promoter of miR-
376b-5p gene. Interestingly, we found 3 binding sites of NF-kBo n
the promoter, with percentage scores as 85, 85.8 and 91.4,
respectively. NF-kB has been shown to provide myocardial
protection by diverse mechanisms including increase of cardiac
Bcl-2 [36,37], induction of manganese superoxide disumutase
[38], and inhibition of leukocyte adhesion, cytokines, and
chemokines [39–42]. In the preconditioning episodes, NF-kBi s
activated and pharmacological inhibition of NF-kB abolishes its
cardioprotective effect [36,43,44]. Moreover, several studies have
demonstrated that M3-mAChR activated NF-kB [18–20], which
may be mediated by intracellular Ca
2+ and PKC-dependent
signaling pathways [19,45]. In the present study, we demonstrated
that NF-kB was activated when M3-mAChR was activated by M3-
mAChR agonist choline in H9c2 cells. Furthermore, LPS, NF-kB
activator, significantly reduced miR-376b-5p expression. Collec-
tively, these data strongly suggest that M3-mAChR inhibits miR-
376b-5p expression via the activation of NF-kB.
In conclusion, our results help establish that a novel M3-
mAChR/NF-kB/miR-376b-5p/BDNF axis plays an important
role in modulating cardioprotection. To our knowledge, this is the
first report to demonstrate that miR-376b-5p promotes myocar-
dial ischemia injury and that the cardioprotection of M3-mAChR
against myocardial ischemia is at least partly mediated by the
downregulation of miR-376b-5p. The present observations
expand our understanding of the cardioprotection of M3-mAChR
associated with ischemic heart disease and may lead to rational
target selection for therapeutic intervention.
Figure 4. BDNF is a target gene of miR-376b-5p in cardiac myocytes. (A) MiR-376b-5p binding site in 39-untranslated region (39-UTR) of BDNF
gene. (B) Inhibitory effects of miR-376b-5p on BDNF expression at the protein level. BDNF level was determined by Western blot after H9c2 cells were
transfected with miR-376b-5p negative control (miR-NC), miR-376b-5p and 29-O-methyl-modified antisense oligoribonucleotides of miR-376b-5p
(AMO-376b-5p, miR-376b-5p inhibitor) for 24 h. GAPDH served as loading control. Top, representative Western blots; bottom, quantitation as mean
6 SEM. Note: n=3; *P,0.05 vs. miR-NC,
#P,0.05 vs. miR-376b-5p. (C) Luciferase assay for direct inhibitory effects of miR-376b-5p on BDNF
expression. The reporter construct was transfected into HEK 293T cells with miR-NC, miR-376b-5p, AMO-376b-5p or AMO-376b-5p negative control
(AMO-NC). Luciferase activity was normalized by Firefly luciferase signal in HEK 293T cells. Following transfection for 24 h, luciferase activities were
measured on a luminometer. Values were expressed as mean 6 SEM; n=3; *P,0.05 vs. miR-NC,
#P,0.05 vs. AMO-NC.
doi:10.1371/journal.pone.0032571.g004
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Figure S1 MiRNA transfection efficiency. (A) Representa-
tive H9c2 cell photomicrographs transfected with miRNA with
fluorescence. (B) MiR-376b-5p level was significantly up-regulated
after transfection with miR-376b-5p. H9c2 cells were transfected
with miR-376b-5p for 24 h. MiR-376b-5p level was determined
by quantitative real-time RT-PCR (qRT-PCR). Note: Values are
expressed as mean 6 SEM; n=3 independent experiments;
*P,0.05 versus Control.
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